Vaccine Scheduler

Poland: Recommended vaccinations

	General recommendation
	Recommendation for specific groups only
	Catch-up (e.g. if previous doses missed)
	Vaccination not funded by the National Health system
	Mandatory vaccination

	Birth	Months								Years
	Birth	2	3	4	5	6	7	13-15	16-18	5	6	10	12-13	14	18
Coronavirus disease (COVID-19)										COVID-19

tuberculosis	BCG³

rotavirus infection		ROTA

diphtheria		D	D		D				D		D			d
tetanus		TT	TT		TT				TT		TT			TT
pertussis		wcP⁴	wcP⁴		wcP⁴				wcP⁴		acP			acp
poliomyelitis			IPV		IPV				IPV		IPV
Haemophilus influenzae type b infection		Hib	Hib		Hib				Hib
hepatitis B	HepB³	HepB					HepB

pneumococcal disease¹		PCV		PCV				PCV

meningococcal disease		MenC					MenC

measles								MEAS			MEAS	MEAS⁵
mumps²								MUMPS			MUMPS	MUMPS⁵
rubella								RUBE			RUBE	RUBE⁵

varicella								VAR

human papillomavirus infection													HPV (F/M)⁶

influenza						IIV3

Version:

Footnotes:

Pneumococcal vaccination introduced in the National Immunisation Programme http://www.dziennikustaw.gov.pl/du/2016/1815/1 https://szczepienia.pzh.gov.pl/szczepionki/pneumokoki/?strona=11#czy-mozna-wymiennie-stosowac-%C2%A010--walentna-i-13--walentna-szczepionke-przeciw-pneumokokom-%C2%A0
More information available at https://szczepienia.pzh.gov.pl/szczepionki/meningokoki/?strona=7#szczepionki-przeciw-meningokokom-w-programie-szczepien-ochronnych
Administration within 24 hours after birth
An acellular pertussis component (aP) combination vaccine should be used for children with contraindications to vaccination with the whole cell pertussis vaccine and in children born before 37th week of pregnancy or born with birth weight less than 2500 g
Catch-up for children who did not receive MMR at 10 years of age. An additional dose should be given by 19 years of age
Primary prevention utilizing HPV vaccination is recommended in the Polish Preventive Vaccination Plan for girls and boys before sexual initiation and according to the schedule recommended by manufacturers. Vaccines are available free of charge for teenage girls/children only in some preventive programs run by local authorities. - Resolution No. 10 of the Council of Ministers of February 4, 2020 on adopting the program Official Journal of the Minister of Health - 27 - Item 117 perennial Mon. National Oncological Strategy for 2020–2030

More information available at:
https://www.gov.pl/web/zdrowie/program-szczepien-ochronnych-pso- http://dziennikmz.mz.gov.pl/DUM_MZ/2021/85/akt.pdf https://szczepienia.pzh.gov.pl/kalendarz-szczepien-2021/

_________________________________________________________________________

MAJOR HISTORICAL CHANGES
Measles, mumps and rubella:
1975: Measles vaccine was introduced into the national childhood vaccination schedule for children aged 13-15 months.

1989: Rubella vaccine (single dose) was introduced into the national childhood vaccination schedule for 13-year old girls.

1991: Second dose of measles vaccine was introduced into the national childhood vaccination schedule for children aged 7 years.

2003: Monovalent measles vaccine given at the age of 13-15 months was replaced by MMR

2005: Second dose of MMR was introduced into the national childhood vaccination schedule for children aged 10 years. An additional catch-up dose of MMR was provided during 2005-2008 at the age of 12 years for all girls not previously vaccinated at the age of 10 years.

2017: Pneumococcal vaccination introduced in the National Immunisation Programme

2020: Introduction of HPV Vaccine in girls and boys as part of the National Oncological Strategy

_________________________________________________________________________

Date of last update: 15 April 2024

_________________________________________________________________________